ArticleLancet regional health. Americas2023

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial.

María Eugenia Toledo-Romaní et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.